Serum, Bharat Biotech vaccines get restricted use approval from DCGI ...Middle East

Business Standard - News
Serum, Bharat Biotech vaccines get restricted use approval from DCGI
While the Oxford-AstraZeneca vaccine made by Serum Institute here has 70.42% efficacy, Bharat Biotech's still does not have efficacy data as trials are underway in India

Read More Details
Finally We wish PressBee provided you with enough information of ( Serum, Bharat Biotech vaccines get restricted use approval from DCGI )

Apple Storegoogle play

Also on site :